0001722024-20-000012.txt : 20200825 0001722024-20-000012.hdr.sgml : 20200825 20200825183617 ACCESSION NUMBER: 0001722024-20-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200825 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC CENTRAL INDEX KEY: 0001722024 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 201133736 BUSINESS ADDRESS: STREET 1: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 BUSINESS PHONE: 626-578-0777 MAIL ADDRESS: STREET 1: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_159839496225044.xml FORM 4 X0306 4 2020-08-25 1 0001815442 Kymera Therapeutics, Inc. KYMR 0001722024 Alexandria Venture Investments, LLC 26 NORTH EUCLID AVENUE PASADENA CA 91101 0 0 1 0 Common Stock 2020-08-25 4 C 0 467932 A 467932 D Series A convertible preferred stock 2020-08-25 4 C 0 500000 D Common Stock 313500.0 0 D Series B convertible preferred stock 2020-08-25 4 C 0 246305 D Common Stock 154432.0 0 D Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 1.5949 shares of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on August 25, 2020, for no additional consideration. The shares had no expiration date. Not applicable. By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer 2020-08-25